DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
DarioHealth Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$4.49−0.33 (-6.85%)
Close on Oct 19, 2026
- Market cap
- $41.95M
- P/E (TTM)
- 1.1
- Dividend yield
- –
DarioHealth Corp. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Services | $14.93M | $20.20M | $13.08M | $17.86M | $2.09M | $1.81M | $2.07M | $236.00K | 66.8% | -26.1% |
| Consumer hardware | $7.43M | $6.84M | $7.27M | $9.80M | $18.43M | – | – | – | 33.2% | +8.6% |
| Products | – | – | – | – | $17.79M | $5.77M | $5.49M | $7.16M | – | – |
| Consumer Products and other revenues | – | – | – | – | – | $4.39M | $4.48M | $6.83M | – | – |
| Membership services | – | – | – | – | – | $3.18M | $2.93M | $562.00K | – | – |
| Consumers | – | – | $8.29M | $11.28M | $19.66M | – | – | – | – | – |
| Commercial | – | – | – | $16.38M | $851.00K | – | – | – | – | – |
| Agreement with National Health Plan | – | – | $962.00K | $1.78M | – | – | – | – | – | – |
| Development Services Per Exclusive Agreement Year One [Member] | – | – | – | $4.00M | – | – | – | – | – | – |
| Development Services Per Exclusive Agreement Year Two [Member] | – | – | $2.49M | $1.51M | – | – | – | – | – | – |
| Commercial - Strategic partnerships | – | – | $7.05M | $12.78M | – | – | – | – | – | – |
| "Commercial - Business-to-Business-to-Consumer (""B2B2C"")" | – | – | $5.01M | $3.59M | – | – | – | – | – | – |
| Development Services Per Exclusive Agreement | – | – | $4.59M | $5.51M | – | – | – | – | – | – |
| Development Services Per Exclusive Agreement Year Three [Member] | – | – | $2.10M | – | – | – | – | – | – | – |
| SaaS services | – | $292.00K | – | – | – | – | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of DarioHealth's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.